Noble Capital Markets Initiates Coverage On YS Biopharma Co With Outperform Rating, Announces Price Target of $5.25
BenzingaNov 14, 2023 01:06
YS Biopharma Co Analyst Ratings
BenzingaNov 14, 2023 01:03
No Data